Condition
Borderline Ovarian Clear Cell Tumor|Borderline Ovarian Serous Tumor|Cervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Small Cell Carcinoma|Cervical Squamous Cell Carcinoma, Not Otherwise Specified|Childhood Embryonal Rhabdomyosarcoma|Childhood Malignant Ovarian Germ Cell Tumor|Endometrioid Stromal Sarcoma|Gestational Trophoblastic Tumor|Malignant Mesothelioma|Malignant Ovarian Epithelial Tumor|Melanoma|Neoplasm of Uncertain Malignant Potential|Ovarian Brenner Tumor|Ovarian Clear Cell Cystadenocarcinoma|Ovarian Serous Cystadenocarcinoma|Paget Disease of the Vulva|Recurrent Cervical Carcinoma|Recurrent Fallopian Tube Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Ovarian Germ Cell Tumor|Recurrent Primary Peritoneal Carcinoma|Recurrent Uterine Corpus Carcinoma|Recurrent Vaginal Carcinoma|Recurrent Vulvar Carcinoma|Stage I Ovarian Cancer|Stage I Uterine Corpus Cancer|Stage I Vaginal Cancer|Stage I Vulvar Cancer|Stage IA Cervical Cancer|Stage IA Fallopian Tube Cancer|Stage IA Ovarian Cancer|Stage IA Ovarian Germ Cell Tumor|Stage IB Cervical Cancer|Stage IB Fallopian Tube Cancer|Stage IB Ovarian Cancer|Stage IB Ovarian Germ Cell Tumor|Stage IC Fallopian Tube Cancer|Stage IC Ovarian Cancer|Stage IC Ovarian Germ Cell Tumor|Stage II Ovarian Cancer|Stage II Uterine Corpus Cancer|Stage II Vaginal Cancer|Stage II Vulvar Cancer|Stage IIA Cervical Cancer|Stage IIA Fallopian Tube Cancer|Stage IIA Ovarian Cancer|Stage IIA Ovarian Germ Cell Tumor|Stage IIB Cervical Cancer|Stage IIB Fallopian Tube Cancer|Stage IIB Ovarian Cancer|Stage IIB Ovarian Germ Cell Tumor|Stage IIC Fallopian Tube Cancer|Stage IIC Ovarian Cancer|Stage IIC Ovarian Germ Cell Tumor|Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor|Stage III Cervical Cancer|Stage III Uterine Corpus Cancer|Stage III Vaginal Cancer|Stage III Vulvar Cancer|Stage IIIA Fallopian Tube Cancer|Stage IIIA Ovarian Cancer|Stage IIIA Ovarian Germ Cell Tumor|Stage IIIA Primary Peritoneal Cancer|Stage IIIB Fallopian Tube Cancer|Stage IIIB Ovarian Cancer|Stage IIIB Ovarian Germ Cell Tumor|Stage IIIB Primary Peritoneal Cancer|Stage IIIC Fallopian Tube Cancer|Stage IIIC Ovarian Cancer|Stage IIIC Ovarian Germ Cell Tumor|Stage IIIC Primary Peritoneal Cancer|Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor|Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer|Stage IV Uterine Corpus Cancer|Stage IVA Cervical Cancer|Stage IVA Vaginal Cancer|Stage IVB Cervical Cancer|Stage IVB Vaginal Cancer|Stage IVB Vulvar Cancer|Uterine Corpus Cancer|Uterine Corpus Leiomyosarcoma|Vulvar Squamous Cell Carcinoma
Estimated Enrollment: 275
Age Group: Child, Adult, Senior
Gender: Female
Study Type: Observational
Study Design Allocation: Observational Model: Cohort|Time Perspective: Prospective
Study ID Numbers: GOG-0136|NCI-2009-00577|GOG-136|CDR0000078647|U10CA180868
Study First Received: May 9, 2009
Last Updated: October 26, 2016
Estimated Primary Completion Date: January 2016
Primary Outcome Measures:
Collection of gynecological tumor specimens and serum from patients at GOG institutions|Create a repository for long-term storage of these specimens|Make available tissue and blood for proposed projects
Sponsors and Collaborators:
Gynecologic Oncology Group|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00897442
